MARILOU LINATOC: Open Payments
NPI 1679506349 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 36 payments from 11 companies in 2025. Trend: 2023 $740 · 2024 $714 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $197 |
| Novo Nordisk Inc | 3 | $62 |
| Exact Sciences Corporation | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $36 |
| Lilly USA, LLC | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $26 |
| Boston Scientific Corporation | 1 | $25 |
Products named: QULIPTA, REXULTI, Cologuard Collection Kit, GVOKE HYPOPEN, Wegovy, FARXIGA, NURTEC ODT, Intracept.
Industry payments across NM — which companies pay providers there.
